Omaxhealth

Health & Beauty · Supplements & Vitamins

Omaxhealth sells omega-3 and cannabinoid-based soft-gels, topicals, and drink mixes aimed at joints, sleep, mood, and skin. Price tier is mid-range to premium: most 60-count omega-3 SKUs run $35-50, while triple-action combos with CBD climb to $70-90. Distribution is DTC-first through omaxhealth.com, Amazon, and Walmart.com; select CVS and Sprouts locations carry the Omega-3 line. The brand’s hook is “pharmaceutical-grade” formulations: patented ProResolv omega-3s, cold-extracted CBD, and third-party potency testing printed on every box. Flagship SKU “Triple Action Omega-3 + CBD” pairs 1 500 mg EPA/DHA with 10 mg hemp cannabinoids in a citrus-flavored mini-soft-gel that won a 2020 NutrAward for finished-product innovation. All batches are distilled in an NSF-certified facility and carry the GOED monogram. Core buyers are 35-60-year-old professionals who exercise, track biomarkers, and want drug-free joint or sleep support; 63 % of site reviews come from repeat customers citing measurable CRP or triglyceride drops. The brand leans on science-over-hype positioning—white-paper downloads and QR-linked lab data—appealing to shoppers who value transparency more than celebrity endorsements. Omaxhealth competes in the crowded premium omega-3 and hemp-CBD aisles against both legacy fish-oil giants and niche hemp brands. It differentiates by combining ultra-concentrated omega-3s with micro-dosed CBD in one clinically referenced soft-gel, then publishing full COAs for every lot—an assurance level mass-market fish oils and boutique CBD startups rarely match.

Pharmaceutical rigor, cannabis precision, one soft-gel that actually measures up